German court finds Praluent infringes Amgen’s German Repatha patent The Pharma Letter
The Düsseldorf Regional Court has found that Praluent (alirocumab) infringes the German part of US biotech firm Amgen’s (Nasdaq: AMGN) European patent …
German court finds Praluent infringes Amgen’s German Repatha patent The Pharma Letter
The Düsseldorf Regional Court has found that Praluent (alirocumab) infringes the German part of US biotech firm Amgen’s (Nasdaq: AMGN) European patent …